BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 35101945)

  • 1. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling.
    Makino K; Long MD; Kajihara R; Matsueda S; Oba T; Kanehira K; Liu S; Ito F
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch Signaling Facilitates In Vitro Generation of Cross-Presenting Classical Dendritic Cells.
    Kirkling ME; Cytlak U; Lau CM; Lewis KL; Resteu A; Khodadadi-Jamayran A; Siebel CW; Salmon H; Merad M; Tsirigos A; Collin M; Bigley V; Reizis B
    Cell Rep; 2018 Jun; 23(12):3658-3672.e6. PubMed ID: 29925006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions.
    Yin X; Yu H; Jin X; Li J; Guo H; Shi Q; Yin Z; Xu Y; Wang X; Liu R; Wang S; Zhang L
    J Immunol; 2017 Feb; 198(4):1553-1564. PubMed ID: 28087664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mesenchymal stem cells from human induced pluripotent stem cells on differentiation, maturation, and function of dendritic cells.
    Gao WX; Sun YQ; Shi J; Li CL; Fang SB; Wang D; Deng XQ; Wen W; Fu QL
    Stem Cell Res Ther; 2017 Mar; 8(1):48. PubMed ID: 28253916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity.
    Balan S; Arnold-Schrauf C; Abbas A; Couespel N; Savoret J; Imperatore F; Villani AC; Vu Manh TP; Bhardwaj N; Dalod M
    Cell Rep; 2018 Aug; 24(7):1902-1915.e6. PubMed ID: 30110645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically applicable CD34
    van Eck van der Sluijs J; van Ens D; Thordardottir S; Vodegel D; Hermens I; van der Waart AB; Falkenburg JHF; Kester MGD; de Rink I; Heemskerk MHM; Borst J; Schaap NPM; Jansen JH; Xiao Y; Dolstra H; Hobo W
    Cancer Immunol Immunother; 2021 Nov; 70(11):3167-3181. PubMed ID: 33796917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis.
    Cooles FAH; Anderson AE; Skelton A; Pratt AG; Kurowska-Stolarska MS; McInnes I; Hilkens CMU; Isaacs JD
    Front Immunol; 2018; 9():755. PubMed ID: 29867920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Generation of Human XCR1(+) Dendritic Cells from CD34(+) Hematopoietic Progenitors.
    Balan S; Dalod M
    Methods Mol Biol; 2016; 1423():19-37. PubMed ID: 27142006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The In Vitro Differentiation of Human CD141+CLEC9A+ Dendritic Cells from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells.
    Swartz AM; Nair SK
    Curr Protoc; 2022 Apr; 2(4):e410. PubMed ID: 35435334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional and Functional Analysis of CD1c
    Bourdely P; Anselmi G; Vaivode K; Ramos RN; Missolo-Koussou Y; Hidalgo S; Tosselo J; Nuñez N; Richer W; Vincent-Salomon A; Saxena A; Wood K; Lladser A; Piaggio E; Helft J; Guermonprez P
    Immunity; 2020 Aug; 53(2):335-352.e8. PubMed ID: 32610077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Generation of Murine CD8α
    Kirkling ME; Reizis B
    Methods Mol Biol; 2023; 2618():109-119. PubMed ID: 36905512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CLEC10A Is a Specific Marker for Human CD1c
    Heger L; Balk S; Lühr JJ; Heidkamp GF; Lehmann CHK; Hatscher L; Purbojo A; Hartmann A; Garcia-Martin F; Nishimura SI; Cesnjevar R; Nimmerjahn F; Dudziak D
    Front Immunol; 2018; 9():744. PubMed ID: 29755453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential.
    Becker AMD; Decker AH; Flórez-Grau G; Bakdash G; Röring RJ; Stelloo S; Vermeulen M; Piet B; Aarntzen EHJG; Verdoes M; de Vries IJM
    Cell Rep Med; 2024 Feb; 5(2):101386. PubMed ID: 38242119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer.
    Mastelic-Gavillet B; Sarivalasis A; Lozano LE; Wyss T; Inoges S; de Vries IJM; Dartiguenave F; Jichlinski P; Derrè L; Coukos G; Melero I; Harari A; Romero P; Viganó S; Kandalaft LE
    Eur J Cancer; 2020 Aug; 135():173-182. PubMed ID: 32590296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OP9-DL1 cell co-culture enhances anti-tumour immunity of mouse bone marrow-derived dendritic cells.
    Feng F; Yang J; Tong L; Yuan S; Tian Y; Hong L; Wang W; Zhang H
    Cell Biol Int; 2012 Mar; 36(3):297-303. PubMed ID: 21906030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD34
    van Eck van der Sluijs J; van Ens D; Brummelman J; Heister D; Sareen A; Truijen L; van Ingen Schenau DS; Heemskerk MHM; Griffioen M; Kester MGD; Schaap NPM; Jansen JH; van der Waart AB; Dolstra H; Hobo W
    Cell Mol Life Sci; 2023 Sep; 80(10):298. PubMed ID: 37728691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Generation of Human Cross-Presenting Type 1 Conventional Dendritic Cells (cDC1s) and Plasmacytoid Dendritic Cells (pDCs).
    Luo X; Balan S; Arnold-Schrauf C; Dalod M
    Methods Mol Biol; 2023; 2618():133-145. PubMed ID: 36905514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior antigen cross-presentation and XCR1 expression define human CD11c+CD141+ cells as homologues of mouse CD8+ dendritic cells.
    Bachem A; Güttler S; Hartung E; Ebstein F; Schaefer M; Tannert A; Salama A; Movassaghi K; Opitz C; Mages HW; Henn V; Kloetzel PM; Gurka S; Kroczek RA
    J Exp Med; 2010 Jun; 207(6):1273-81. PubMed ID: 20479115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Inflammatory CD14
    Iwabuchi R; Ide K; Terahara K; Wagatsuma R; Iwaki R; Matsunaga H; Tsunetsugu-Yokota Y; Takeyama H; Takahashi Y
    Front Immunol; 2021; 12():643040. PubMed ID: 33790912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.